IL6 and tuberculosis: In the present study, apparently for the first time, an effort has been made to project the elaboration of IL-6, as a sequel to the interaction of PMs with mycobacteria, in vitro, as a potential biomarker of mycobacterial infection, either stand-alone or along with other cytokines, which may be developed further as a biomarker/biosignature of TB.